Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vopikitug - Roche

Next Previous
Search
Drug Profile

Vopikitug - Roche

Alternative Names: RG 6292; RO 7296682

Latest Information Update: 16 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Roche
  • Class Antineoplastics; Immunotherapies; Monoclonal antibodies
  • Mechanism of Action Antibody-dependent cell cytotoxicity; Phagocyte stimulants; Regulatory T-lymphocyte inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Acute myeloid leukaemia
  • Discontinued Solid tumours

Most Recent Events

  • 16 Aug 2024 Discontinued - Phase-I for Solid tumours (Combination therapy, Late-stage disease, Metastatic disease, Second-line therapy or greater) in Australia, Belgium, Canada, Denmark, Spain (IV) (Roche pipeline, August 2024)
  • 16 Aug 2024 Discontinued - Phase-I for Solid tumours (Late-stage disease, Metastatic disease, Monotherapy, Second-line therapy or greater) in Australia, Belgium, Denmark, Canada, Spain (IV) (Roche pipeline, August 2024)
  • 14 Apr 2023 RG 6292 is still in phase I trials for Solid tumours (Monotherapy, Late-stage disease, Metastatic disease, Second-line therapy or greater) in Denmark, Spain, Canada, Belgium and Australia (IV) (NCT04158583)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top